Financials

  • Market Capitalization 5.02 B
  • Employee 798
  • Founded 1993
  • CEO Catherine Owen Adams
  • Website www.acadia.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHG9K0
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
11.61
Fiyat/satışlar oranı
4.24

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1279
CRSP
CRISPR Therapeutics AG - Common Shares
57.72 USD-2.78%-1.52%+21.01%+13.18%5.58 B USD
1289
DFTX
Definium Therapeutics, Inc. - Common Shares
40.98 USD-6.48%-7.64%-3.10%+171.21%5.51 B USD
1399
DYN
Dyne Therapeutics, Inc. - Common Stock
25.07 USD-3.91%-4.06%+2.33%+7.09%4.68 B USD
1406
EWTX
Edgewise Therapeutics, Inc. - Common Stock
42.76 USD-3.24%-3.21%+8.17%+180.76%4.64 B USD

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc., merkezi Kaliforniya’nın Del Mar kentinde bulunan bir biyofarmasötik şirkettir.

Haberler